Verteporfin

Welcome to Dwaey, specifically on Verteporfin page.
This medicine contains important and useful components, as it consists of
Verteporfin is available in the market in concentration.

Generic Name of Verteporfin - Learn More

Verteporfin

Verteporfin Precaution - What You Need to Know

Before starting Verteporfin, it is essential that patients consult their healthcare provider to ensure its suitability based on their medical history and condition. Important precautions include:
- Photosensitivity: Verteporfin causes increased sensitivity to light, especially after administration. Patients should avoid direct exposure to bright light, including sunlight, for at least 48 hours following the treatment. Protective measures, such as wearing dark sunglasses and avoiding outdoor activities during this period, are strongly recommended.
- Liver Function: Verteporfin is metabolized by the liver, and patients with liver impairment may require dose adjustments or monitoring for potential toxicity. Liver function tests should be monitored before and during treatment.
- Eye Health: Prior to treatment, a full eye examination should be performed, especially for patients with pre-existing macular degeneration or retinal conditions. In rare cases, Verteporfin may cause adverse effects on vision.
- Pregnancy and Breastfeeding: The safety of Verteporfin during pregnancy is not well established. It should be used only if the potential benefit outweighs the risks. It is also unknown if Verteporfin is excreted in breast milk, so nursing mothers should consult their healthcare provider before using the drug.

Verteporfin Indication - Uses and Benefits

Verteporfin is primarily indicated for the treatment of age-related macular degeneration (AMD) and other retinal vascular diseases:
- Macular Degeneration: It is used in the treatment of wet age-related macular degeneration (wet AMD), a condition characterized by the growth of abnormal blood vessels beneath the retina, which can lead to vision loss.
- Choroidal Neovascularization: Verteporfin is also used for the treatment of choroidal neovascularization (CNV) secondary to other conditions, such as myopic CNV and pathological myopia, which are also linked to retinal damage.
- Photodynamic Therapy (PDT): Verteporfin is administered in combination with photodynamic therapy (PDT). The drug is activated by laser light, which selectively destroys the abnormal blood vessels causing damage in the retina.

Verteporfin Contraindications - Important Warnings

Verteporfin should not be used in the following situations:
- Hypersensitivity: Patients who are allergic to Verteporfin or any of its ingredients should not use it.
- Severe Liver Impairment: The drug should be avoided in individuals with severe liver dysfunction, as it can increase the risk of liver toxicity due to the drug's metabolism in the liver.
- Pregnancy: Verteporfin is contraindicated during pregnancy, as it has not been studied for safety in pregnant women, and the potential risks to the fetus are unknown.
- Severe Retinal Disease: In some cases, patients with extensive retinal damage or conditions not responsive to PDT may not benefit from Verteporfin therapy. This should be evaluated by an eye care professional.

Verteporfin Side Effects - What to Expect

Common side effects of Verteporfin include:
- Photosensitivity: This is the most common side effect, where patients may experience increased sensitivity to sunlight or bright indoor light. Protective measures should be followed as instructed.
- Injection Site Reactions: Mild pain, redness, or swelling may occur at the injection site.
- Visual Changes: Temporary visual disturbances, such as blurred vision or visual discomfort, may occur during or after the procedure.
- Headache: Some patients may experience headaches following the treatment.
- Flu-like Symptoms: Fever, chills, muscle pain, or other flu-like symptoms may occur, though these are typically temporary.

Serious side effects, though rare, include:
- Severe Vision Changes: Uncommon, but in some cases, Verteporfin can worsen vision loss or cause permanent damage to the retina, especially in patients with pre-existing retinal conditions.
- Anaphylactic Reaction: There have been reports of allergic reactions to Verteporfin, including anaphylaxis. Patients should seek immediate medical attention if they experience swelling, difficulty breathing, or skin rashes.
- Liver Toxicity: In rare cases, liver damage has been reported, particularly in patients with pre-existing liver conditions. Monitoring liver function is advised.

Verteporfin Pregnancy Category ID - Safety Information

3

Verteporfin Mode of Action - How It Works

Verteporfin works as part of a process known as photodynamic therapy (PDT). The mechanism involves:
- Selective Activation by Light: After intravenous administration, Verteporfin accumulates in abnormal blood vessels under the retina. It is then activated by exposure to a specific wavelength of laser light.
- Production of Reactive Oxygen Species (ROS): The laser light triggers the Verteporfin to generate reactive oxygen species, which cause oxidative damage to the endothelial cells lining the abnormal blood vessels.
- Vascular Occlusion: This damage leads to the clotting and occlusion of the abnormal blood vessels, which effectively reduces or halts the leakage and growth of these vessels, thereby preventing further damage to the retina and improving vision.

Verteporfin Drug Interactions - What to Avoid

Verteporfin can interact with several medications and substances:
- Photosensitizing Drugs: Drugs that increase sensitivity to light, such as certain antibiotics (e.g., tetracyclines) or sulfonamides, may increase the phototoxic effects of Verteporfin.
- Cytochrome P450 Enzyme Inhibitors: Medications that inhibit liver enzymes, particularly CYP3A4 (such as ketoconazole, itraconazole, or clarithromycin), may alter the metabolism of Verteporfin and increase its concentration in the blood. This could potentially enhance side effects.
- Warfarin and Anticoagulants: Caution should be exercised when using Verteporfin with blood-thinning medications like warfarin, as the photodynamic therapy may cause bleeding or bruising.
- Other Photosensitizing Agents: Other medications or compounds that increase sensitivity to light should be avoided in combination with Verteporfin. It is crucial to avoid drugs that may heighten the risk of photosensitivity during treatment.

Verteporfin Adult Dose - Recommended Dosage

The typical dosing regimen for Verteporfin in adults is as follows:
- Initial Dose: The recommended dose is 6 mg/m² of body surface area, administered intravenously over a 10-minute period.
- Light Activation: After the injection, the patient is exposed to laser light within 15 minutes to activate the drug and initiate the photodynamic therapy.
- Repeat Treatments: Treatments are usually repeated every 3 months, depending on the patient's condition and response to therapy. The number of treatments may vary based on the severity of the condition and the patient's progress.

Verteporfin Child Dose - Dosage for Children

Verteporfin is not approved for use in pediatric populations, and its safety and efficacy in children have not been established. Use of Verteporfin in children should be considered only under strict medical supervision and when other treatment options are not available or appropriate.

It is important to consult a healthcare provider before initiating treatment with Verteporfin, as they can provide detailed guidance tailored to the patient’s specific condition and monitor for potential side effects during and after the treatment process.

Verteporfin Renal Dose - Dosage for Kidney Conditions

There are no specific dose adjustments for Verteporfin in patients with renal impairment. However, caution should be exercised when administering Verteporfin to patients with severe renal impairment, and these patients should be monitored closely for any adverse effects. There is limited data on the use of Verteporfin in patients with end-stage renal disease, so clinical judgment should guide its use in these individuals.